Meyka Pro banner
Henry Schein, Inc.

Henry Schein, Inc. (HSIC) Stock Overview

Explore Henry Schein, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HSICNASDAQ
HealthcareMedical - Distribution
$88.50
$0.04(0.05%)
U.S. Market opens in 62h 58m

Henry Schein, Inc. (HSIC)

Meyka AI Score

Z

Key Financials

Market Cap10.1B
P/E Ratio25.54
EPS (TTM)$5.31
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$91.20
3 Months$83.50
1 Year Target$80.61

HSIC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Henry Schein, Inc. (NASDAQ: HSIC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Henry Schein, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HSIC on the NASDAQ shows an RSI of 56.19, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $80.61 for the NASDAQ listing.

Key metrics behind Henry Schein, Inc.'s NASDAQ-traded stock include a P/E ratio of 25.54 and a market capitalization of 10.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HSIC on the NASDAQ.

Price Performance (NASDAQ: HSIC)

1-Day Change
0.05%
5-Day Change
-1.76%
1-Month Change
3.07%
3-Month Change
20.41%
6-Month Change
11.22%
Year-to-Date (YTD) Change
17.09%
1-Year Change
29.75%
3-Year Change
15.78%
5-Year Change
16.85%
All-Time (Max) Change
1883.96%

Contact Information

631 843 5500
135 Duryea Road, Melville, NY, 11747

Company Facts

250,000 Employees
IPO DateNov 3, 1995
CountryUS
Actively Trading

Frequently Asked Questions